C167 Pill: white, capsule/oblong, 17mm
The pill with imprint C167 (White, Capsule/Oblong, 17mm) has been identified as Lamivudine 300 mg and is used for Hepatitis B, HIV Infection, Nonoccupational Exposure, and Occupational Exposure. It belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is not a controlled substance.
Images for C167
Lamivudine
- Imprint
- C167
- Strength
- 300 mg
- Color
- White
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0167
- Inactive Ingredients
-
hypromellose 2910 (15 mPa.s),
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type B potato,
polyethylene glycol 6000,
corn starch,
titanium dioxide
Note: Inactive ingredients may vary.
See also:
More about lamivudine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.